Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 5 | BES2003 | Next issue

22nd Joint Meeting of the British Endocrine Societies

Poster Presentations

Endocrine Tumours and Neoplasia

Previous section
Diabetes, Metabolism and Cardiovascular
Table of contents
Next section
Growth and Development

ea0005p114 | Endocrine Tumours and Neoplasia

Familial isolated primary hyperparathyroidism due to germline multiple endocrine neoplasia Type 1 (MEN1) mutations

ea0005p115 | Endocrine Tumours and Neoplasia

Prostate and ovarian cancer cell responses to treatment with 2-substituted oestrogen sulphamates in vitro

ea0005p116 | Endocrine Tumours and Neoplasia

Dysregulated extra-renal synthesis of 1,25-dihydroxyvitamin D3: A novel cause of hypercalcemia associated with ovarian dysgerminomas

ea0005p117 | Endocrine Tumours and Neoplasia

Parathyroid tumours harbour parafibromin somatic mutations, consistent with the Knudson 'two-hit' hypothesis

ea0005p118 | Endocrine Tumours and Neoplasia

Genetic abnormalities in carcinoid tumours

ea0005p119 | Endocrine Tumours and Neoplasia

Hyperparathyroidism-jaw tumour syndrome (HPT-JT) in Romany families from Portugal is due to a founder mutation of parafibromin

ea0005p120 | Endocrine Tumours and Neoplasia

Clinical and biochemical prognostic indicators at diagnosis in 117 midgut carcinoid tumours

ea0005p121 | Endocrine Tumours and Neoplasia

Differential modulation of key steroidogenic enzymes through orphan nuclear transcriptional regulation may control the diverse production of cortisol and adrenal androgens

ea0005p122 | Endocrine Tumours and Neoplasia

IL1 alpha, IL6 and MMP13 are required for invasion by the human pituitary cell line HP75

ea0005p123 | Endocrine Tumours and Neoplasia

Preoperative determination of serum thyroglobulin may identify patients with differentiated thyroid cancer who might recur without increased thyroglobulin

ea0005p124 | Endocrine Tumours and Neoplasia

Acromegaly: A study of epidemiological characteristics and treatment outcomes

ea0005p125 | Endocrine Tumours and Neoplasia

Dysregulation of the Vitamin D axis in colorectal cancer

ea0005p126 | Endocrine Tumours and Neoplasia

Outcomes in acromegaly: A retrospective study of 419 patients from the West Midlands region of the United Kingdom

ea0005p127 | Endocrine Tumours and Neoplasia

Proliferative regulation of human breast cancer cells by dietary phytoestrogens: Mechanisms of estrogen receptor-mediated signalling

ea0005p128 | Endocrine Tumours and Neoplasia

CYP27b and CYP24 expression combine to determine 1,25 Dihydroxyvitamin D3 insensitivity in breast cancer cells

ea0005p129 | Endocrine Tumours and Neoplasia

Stable iodide and radioiodide transport in extrathyroidal tissues

ea0005p130 | Endocrine Tumours and Neoplasia

Identification of the ACTH receptor in the human pituitary and its loss of expression in pituitary adenomas

ea0005p131 | Endocrine Tumours and Neoplasia

The presence of ghrelin protein in the rat hypothalamus and the effect of ghrelin on corticotrophin releasing hormone (CRH) and arginine vasopressin (AVP) release from rat hypothalamic explants pituitary tumours

ea0005p132 | Endocrine Tumours and Neoplasia

Pituitary tumor transforming gene upregulates its binding factor PBF in vitro

ea0005p133 | Endocrine Tumours and Neoplasia

Insulin-like growth factor binding protein-3 (IGFBP-3) expression in the caecum and rectum of patients with and without acromegaly

ea0005p134 | Endocrine Tumours and Neoplasia

Expression of IGF-I in normal and malignant breast tissue and its association with tumour size

ea0005p135 | Endocrine Tumours and Neoplasia

Expression of IGFBP-3 mRNA in breast cancer in relation to clinical phenotype

ea0005p136 | Endocrine Tumours and Neoplasia

Methylation status and iodide uptake

ea0005p137 | Endocrine Tumours and Neoplasia

Prolactinoma volume and serum prolactin level: Evidence for the 'silent lactotroph' tumour

ea0005p138 | Endocrine Tumours and Neoplasia

Lipocortin-1 expression within normal and abnormal endometrium

ea0005p139 | Endocrine Tumours and Neoplasia

Co-regulators SRC-1 and SMRT interact with ER-alpha and ER-beta in human breast cancer

ea0005p140 | Endocrine Tumours and Neoplasia

Pituitary irradiation for recurrent steroid-responsive hypophysitis in three patients

ea0005p141 | Endocrine Tumours and Neoplasia

Abnormal expression of 11beta-hydroxysteroid dehydrogenase 2 in primary cultures of human pituitary adenomas

ea0005p142 | Endocrine Tumours and Neoplasia

Cell cycle dysregulation in parathyroid adenoma and carcinoma

ea0005p143 | Endocrine Tumours and Neoplasia

Transcriptional regulation by PEA3 in human breast cancer

ea0005p144 | Endocrine Tumours and Neoplasia

Metaiodobenzylguanidine scintigraghy (MIBG) and familial screening are not useful in phaeochromocytoma

ea0005p145 | Endocrine Tumours and Neoplasia

Molecular genetic diagnosis for disorders of calcium metabolism

ea0005p146 | Endocrine Tumours and Neoplasia

Expression of somatostatin receptors in proliferating and quiescent endothelial cells

ea0005p147 | Endocrine Tumours and Neoplasia

Insulinoma, diabetes and islet cell amyloid polypeptide

ea0005p148 | Endocrine Tumours and Neoplasia

A TSH response to a single octreotide test dose predicts a long term response to somatostatin analogue therapy in patients with a TSH-secreting pituitary adenoma

ea0005p149 | Endocrine Tumours and Neoplasia

Usefulness of growth hormone response to a test dose of subcutaneous octreotide in predicting longer-term response to the drug. Poor responses predict the need for adjuvant therapy to achieve 'safe' growth hormone levels

ea0005p150 | Endocrine Tumours and Neoplasia

Expression of vascular endothelial growth factor and its receptors in human anterior pituitary adenomas

ea0005p151 | Endocrine Tumours and Neoplasia

IGF-I inhibits COX-2 function in primary colonic biopsies of patients with acromegaly

ea0005p152 | Endocrine Tumours and Neoplasia

Can petrosal sinus ACTH and prolactin responses to CRH help localize the tumour in Cushing's disease due to pituitary microadenomas?

ea0005p153 | Endocrine Tumours and Neoplasia

A rapid method for analysing serum pro-insulin-like growth factor-II (pro-IGF-II) in patients with non-islet cell tumour hypoglycaemia (NICTH)

ea0005p154 | Endocrine Tumours and Neoplasia

A new role for the endocrine nurse within a multidisciplinary approach to neuroendocrine tumours

ea0005p155 | Endocrine Tumours and Neoplasia

Transsphenoidal surgery for acromegaly in Wales: Results based on stringent criteria of remission

ea0005p156 | Endocrine Tumours and Neoplasia

Carney complex type 1 gene (PRKAR1A) expression and sequence analysis in sporadic somatotroph and other pituitary tumours

ea0005p157 | Endocrine Tumours and Neoplasia

Elevated alpha fetoprotein levels in association with a metastatic neuroendocrine tumour

ea0005p158 | Endocrine Tumours and Neoplasia

Retrospective audit of care of patients undergoing pituitary surgery in Plymouth

ea0005p159 | Endocrine Tumours and Neoplasia

Lymphocytic adenohypophysitis occurring simultaneously with an ACTH secreting adenoma

ea0005p160 | Endocrine Tumours and Neoplasia

Double trouble. Dual pathology and false positive as well as false negative imaging in a man with phaeochromocytoma and hypogonadism

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more